Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma

2008292 citationsJournal Articlebronze Open Access

Authors

Eiji Kikuchi · Cornell University

Vitaly Margulis · Cornell University

Pierre I. Karakiewicz · Cornell University

Marco Roscigno · Cornell University

Shuji Mikami · Cornell University

Yair Lotan · Cornell University

Mesut Remzi ·

Abstract

LVI was an independent predictor of clinical outcomes in nonmetastatic patients who underwent RNU for UTUC. Assessment of LVI may help identify patients who could benefit from multimodal therapy after RNU. After confirmation, LVI should be included in staging of UTUC.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Esophageal Cancer Research and Treatment Lymphatic System and Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 27, Issue 4, pp. 612-618

DOI: 10.1200/jco.2008.17.2361

Field-Weighted Citation Impact: 13.08